FDA Inspection 1053000 — Transplant Services Center UT Southwestern Medical Center
The FDA completed an inspection of Transplant Services Center UT Southwestern Medical Center on Apr 24, 2018 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 24, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)